Tag - CYTR

Feature

Centurion BioPharma targeting strategic alliance for LADR drug conjugates by year’s end

By Len Zehrs Centurion BioPharma, a newly-created private subsidiary of CytRx (NASDAQ:CYTR), is currently in discussions with a number of pharma companies for a strategic alliance to continue development of its patient...

July 10, 2018

Feature

CytRx awaiting soft tissue sarcoma data in December

By Len Zehr What if it were possible to deliver a broad range of potent cancer drugs more optimally, enhancing both their safety and efficacy? That’s the question CytRx (NASDAQ:CYTR) hopes to answer this December when...

October 15, 2013

Tag - CYTR

Centurion BioPharma targeting strategic alliance for LADR drug conjugates by year’s end

CytRx awaiting soft tissue sarcoma data in December

General

More